Shareholder

Nancy Sacco appointed Chief Development Officer

Hexima announces the appointment of Dr Nancy Sacco, PhD as Chief Development Officer. Dr Sacco will report to Michael Aldridge, Managing Director & CEO. Dr Sacco brings over 20 years of strong leadership experience in the pharmaceutical industry, driving business...

read more

Annual General Meeting 2021

The Hexima Limited Annual General meeting was held on 2 December 2021 at 11am. A copy of the CEO presentation and a recording of the meeting are available below. Due to Government restrictions and public health advice regarding public gatherings during the COVID-19...

read more

The Market Herald Interview

Hexima's CEO, Mr Michael Aldridge spoke to Sonia Madigan on The Deal Room by The Market Herald regarding its recent capital raise and what to expect next. The Market Herald is the leading source of authoritative breaking stock market news for self-directed investors....

read more

NailMail Q3 2021

Hexima is proud to release its “NailMail” quarterly activities report for the quarter ended 30 September 2021. Major achievements covered in this report include: Filing design patents covering important consumer-orientated elements of CompliancePak, Hexima's novel...

read more

KOL Interviews

Hexima recently took the opportunity to speak with some of the members of its Scientific Advisory Board about Onychomycosis: the disease, its treatment and the potential for a new therapy like pezadeftide. You can view the insightful responses from Dr Robert Rosen, Dr...

read more

Hexima Presenting at AusBiotech

Mr Michael Aldridge, CEO of Hexima, presented today at AusBiotech’s “Australia Biotech Invest & Partnering Conference 2021”. AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life...

read more

Consumer Centric Investor Webinar

Watch Hexima CEO, Mr Michael Aldridge, and Hexima's Commercial Consultant, Mr Phil Rose, discuss how Hexima is taking a consumer-centric view on product development to create a treatment that adequately meets the needs of patients. Hexima's Consumer-Centric webinar...

read more